Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach

• Main Authors: Lobna Al-Zaidan (Author), Rasha Abu El Ruz (Author), Ahmed M. Malki (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Metformin is a commonly prescribed antihyperglycemic drug, and has been investigated in vivo and in vitro for its effect to improve the comorbidity of diabetes and various types of cancers. Several studies investigated the therapeutic mechanisms of metformin on cancer cells, but the exact mechanism...